Scarica l'app Stockscreener
3.38
5.96%
0.19
Optimi Health Corp Borsa (OPTH) Ultime notizie
Optimi Health to Present at the ThinkEquity Conference - GlobeNewswire Inc.
Optimi Health Corp. (OPTI.CN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Optimi Health releases 5 mg psilocybin batch for Canadian Phase 2 trial - mugglehead.com
Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - kalkine.com.au
Optimi Health Corp. Plans Health Canada-Authorized Phase 3 Trial of MDMA-Assisted Therapy for PTSD - Quiver Quantitative
Optimi Health Corp Share PriceOPTI, RNS News, Articles, Quotes, & Charts (CNSX:OPTI) - Proactive financial news
OPTI: Commercially supplying natural psychedelics, expanding globally as regulations advance - TradingView
Optimi Health at H.C. Wainwright conference: early lead in psychedelics - Investing.com
OPTI: Commercial psychedelic manufacturer expands globally as regulatory momentum accelerates - TradingView
Optimi Health Corp. (CN:OPTI) Advances as Psychedelic Medicine Pipeline and Clinical Expansion Improve Investor Sentiment - kalkine.ca
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com Nigeria
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com South Africa
OPTH Stock Price, Quote & News - Syfe
OPTH Looks 64.2% Overvalued on GF Value™ - GuruFocus
Optimi Health Launches Health Canada-Authorized Phase 2 Psilocybin Trial for Major Depressive Disorder - kalkine.ca
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com Canada
Optimi Health To Initiate Phase 2 Psilocybin Trial For Major Depression - RTTNews
Optimi Health plans phase 2 psilocybin trial for depression - Investing.com
Optimi Health CorpTrial Initiation Planned For H1 2027, Dosing To Complete By End Of 2027 - TradingView
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com India
Optimi Health Announces Health Canada-Authorized Phase 2 Trial of Natural Psilocybin for Major Depressive Disorder - Quiver Quantitative
A 200-person psilocybin depression trial is coming from Optimi Health (OPTH); here’s when and where - Stock Titan
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder - Yahoo Finance
Optimi Health Stock Under Pressure: Can Psychedelic Growth Overcome Rising Execution and Funding Risks? - kalkine.ca
Optimi Health to Present at H.C. Wainwright Global Investment Conference - TipRanks
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Investing News Network
Optimi Health Corp. to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
Psychedelic-drug maker Optimi Health (OPTH) plans investor meetings in New York - Stock Titan
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Optimi Health Stock Faces Renewed Pressure as Psychedelic-Sector Sentiment Weakens - kalkine.ca
Optimi Health (CN:OPTI) Drops 4.12% as Revenue Weakness, Funding Risk and Psychedelic-Sector Uncertainty Pressure Sentiment - kalkine.ca
Optimi Health Corp (CN: OPTI) Share Price, OPTI Stock News, OPTI Share Price & Updates - kalkine.ca
Optimi Health (OPTH) lines up discounted share funding with new $100M facility - Stock Titan
Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - kalkine.ca
Optimi Health Corp. SEC Filing (Aug 26, 2026) - Stock Titan
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo! Finance Canada
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo Finance
Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances - Yahoo Finance
Optimi Health (OPTH) Stock Chart and Price History 2026 - MarketBeat
Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion - TipRanks
Optimi Health (OPTH) clears way for resale of shares over 3x its float - Stock Titan
Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners - Stock Titan
Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots - kalkine.ca
Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer - Stock Titan
Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots | OPTH Stock News - Quiver Quantitative
Optimi Health Establishes Discretionary Equity Facility - Yahoo Finance
Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots - Quiver Quantitative
Optimi Health Establishes Discretionary Equity Facility - globenewswire.com
Norton Rose Fulbright advises Optimi Health on equity facility - Norton Rose Fulbright
Norton Rose Fulbright advises Optimi Health on equity facility - Norton Rose Fulbright
5.30%
1.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):